Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors
Condition(s):Cardiac Toxicity; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:January 17, 2013Completed